FDA Inspection
Siegfried Hameln GmbHSiegfried Hameln GmbH – FDA Inspection, Jun 14, 2012
Record Details
This FDA Inspection record concerns Siegfried Hameln GmbH, with an inspection on June 14, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Siegfried Hameln GmbH
- Inspection Date
- June 14, 2012
- Product Type
- Drugs
View Company Profile
ID · ee325421-5a50-4446-ab22-7f225fce421f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 786813
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Siegfried Hameln GmbH
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Siegfried Hameln GmbH
- FDA Inspection 1203347 - 2022-09-01
- FDA Inspection 1050123 - 2018-04-24
- FDA Inspection 987428 - 2016-07-01
- FDA Inspection 887446 - 2014-07-25
- FDA Inspection 637807 - 2009-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.